Yun Xu

1.2k total citations
52 papers, 732 citations indexed

About

Yun Xu is a scholar working on Otorhinolaryngology, Molecular Biology and Oncology. According to data from OpenAlex, Yun Xu has authored 52 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Otorhinolaryngology, 19 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Yun Xu's work include Head and Neck Cancer Studies (21 papers), Cancer-related molecular mechanisms research (7 papers) and Head and Neck Surgical Oncology (7 papers). Yun Xu is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Cancer-related molecular mechanisms research (7 papers) and Head and Neck Surgical Oncology (7 papers). Yun Xu collaborates with scholars based in China, United States and Germany. Yun Xu's co-authors include Yaqing Huang, Jianji Pan, Jingting Jiang, Xiping Jiang, Qiaojuan Guo, Yi Zhou, Lujun Chen, Bin Xu, Changping Wu and Bijuan Chen and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Yun Xu

50 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun Xu China 17 360 265 179 170 101 52 732
Mirosław Śnietura Poland 16 269 0.7× 161 0.6× 217 1.2× 141 0.8× 130 1.3× 49 757
Pawadee Lohavanichbutr United States 14 555 1.5× 356 1.3× 202 1.1× 290 1.7× 123 1.2× 15 925
Xifa Zhou China 16 583 1.6× 354 1.3× 190 1.1× 22 0.1× 40 0.4× 34 817
М. К. Ибрагимова Russia 13 211 0.6× 118 0.4× 217 1.2× 28 0.2× 74 0.7× 78 507
Sherianne Ricks United States 7 266 0.7× 71 0.3× 195 1.1× 52 0.3× 68 0.7× 8 524
Ryan C. Chai Australia 12 299 0.8× 91 0.3× 124 0.7× 101 0.6× 74 0.7× 22 486
Céline Clémenson France 15 238 0.7× 89 0.3× 299 1.7× 22 0.1× 33 0.3× 24 613
A. Mazo Spain 10 247 0.7× 86 0.3× 242 1.4× 38 0.2× 114 1.1× 19 577
Enilze Maria de Souza Fonseca Ribeiro Brazil 13 412 1.1× 284 1.1× 111 0.6× 32 0.2× 29 0.3× 45 556
Jean-Philippe Cosse Belgium 8 316 0.9× 313 1.2× 158 0.9× 12 0.1× 19 0.2× 9 611

Countries citing papers authored by Yun Xu

Since Specialization
Citations

This map shows the geographic impact of Yun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Xu more than expected).

Fields of papers citing papers by Yun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Xu. The network helps show where Yun Xu may publish in the future.

Co-authorship network of co-authors of Yun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Xu. A scholar is included among the top collaborators of Yun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Xu. Yun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weng, Youliang, Yun Xu, Yuhui Pan, et al.. (2024). Selection of induction chemotherapy cycles for stage N3 nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA. Scientific Reports. 14(1). 24484–24484.
2.
Luo, Rong, Min Yu, Zheng Su, et al.. (2024). The Eclipse-Radiotherapy Combined with ICI Orchestrates CD8+ T Cell- and NK Cell-Dependent Anti-Tumor Efficacy against Bulky Tumors. International Journal of Radiation Oncology*Biology*Physics. 120(2). S95–S95. 1 indexed citations
3.
Lu, Tianzhu, Jingfeng Zong, Yun Xu, et al.. (2023). Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity‐modulated radiotherapy treatment of T4 nasopharyngeal carcinoma. Head & Neck. 45(5). 1130–1140. 4 indexed citations
4.
Shen, Aijun, Gangmin Wang, Xianfu Meng, et al.. (2023). An Adaptable Nanoprobe Integrated with Quantitative T 1 ‐Mapping MRI for Accurate Differential Diagnosis of Multidrug‐Resistant Lung Cancer. Advanced Healthcare Materials. 12(31). e2300684–e2300684. 3 indexed citations
5.
Li, Ying, Wei Liu, Yun Xu, et al.. (2023). Impact of Radiotherapy Combined With Chemotherapy on Long-Term Outcomes of Patients With Recurrent Nasopharyngeal Carcinoma. Technology in Cancer Research & Treatment. 22. 2223897609–2223897609. 2 indexed citations
8.
Lin, Cheng, Sheng Lin, Li Zhu, et al.. (2022). Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis. BMC Cancer. 22(1). 35–35. 7 indexed citations
9.
Skokowa, Julia, Birte Hernandez Alvarez, M.P. Coles, et al.. (2022). A topological refactoring design strategy yields highly stable granulopoietic proteins. Nature Communications. 13(1). 2948–2948. 9 indexed citations
10.
Xu, Yun, Mengwei Chen, Qiaojuan Guo, et al.. (2021). Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy. Oral Oncology. 121. 105435–105435. 3 indexed citations
11.
Liu, Mengying, et al.. (2021). Hydroxyl radical-involved cancer therapy via Fenton reactions. Frontiers of Chemical Science and Engineering. 16(3). 345–363. 9 indexed citations
12.
Guo, Qiaojuan, Nan Xiao, Jingfeng Zong, et al.. (2021). Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline. Radiotherapy and Oncology. 167. 239–243. 9 indexed citations
13.
14.
Zong, Jingfeng, Bijuan Chen, Qiaojuan Guo, et al.. (2019). Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma. Radiation Oncology. 14(1). 182–182. 21 indexed citations
15.
Shao, Ying, Wei Chong, Xiaoli Liu, et al.. (2019). Alternative splicing-derived intersectin1-L and intersectin1-S exert opposite function in glioma progression. Cell Death and Disease. 10(6). 431–431. 21 indexed citations
16.
Bao, Jie, et al.. (2018). LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Biomedicine & Pharmacotherapy. 107. 824–833. 42 indexed citations
17.
Xu, Yun, Qiaojuan Guo, Jin Lin, et al.. (2016). Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma. OncoTargets and Therapy. Volume 9. 6835–6841. 14 indexed citations
18.
Xu, Yun, Jing Zong, Ju‐Li Lin, et al.. (2016). Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma. Cancer/Radiothérapie. 20(5). 377–383. 3 indexed citations
20.
Han, Lu, et al.. (2013). Therapeutic effect of radiotherapy and chemotherapy in 202 elderly patients with nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 22(6). 461–464. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026